Hakimian, M., & Noori, R. (2018). The relationship between Pembrolizumab for the treatment of PD-L1 positive advanced in cell lung cancer. International Pharmacy Acta, 1(1), 154–154. https://doi.org/10.22037/ipa.v1i1.20499